Quidel Completes Acquisition of Diagnostic Hybrids
Quidel Corp has completed its previously announced acquisition of Diagnostic Hybrids Inc for approximately $130 million in cash.
Read MoreMonth: February 2010
Caliper Forms Scientific Advisory Board for Next Generation Sequencing
Caliper Life Sciences Inc has announced the formation of a scientific advisory board to guide its efforts in automated sample preparation for next generation and third generation sequencing platforms.
Read MoreRoche, Merck Collaborate on Developmental Test for Cancer-Related Gene Mutation
Roche Molecular Systems announced today a research collaboration with Merck Sharp & Dohme Corp (a subsidiary of Merck & Co Inc.) providing Merck access to Roche’s developmental microarray-based AmpliChip p53 test, which is designed to detect mutations in the tumor suppressor gene p53.
Read MoreScientists Develop Personalized Blood Tests for Cancer Using Whole Genome Sequencing
Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients treatments.
Read MoreBG Medicine, Merck Collaborate on Blood Test Related to Lipid Disorders
BG Medicine Inc has announced that it has entered into a research collaboration with Merck, through a subsidiary, for the development and validation of a novel biomarker with potential application in the management of lipid disorders.
Read More